Supply of Roche Inflammatory Marker Reagents (CRP, hs-CRP)

The contract pertains to the supply of Roche reagents for C-reactive protein and high-sensitivity CRP testing, intended for use in inflammation monitoring within clinical settings. These reagents are critical diagnostic tools used to assess inflammatory conditions, track disease progression, and guide treatment decisions, particularly in veteran healthcare environments. The agreement is structured as a subcontract under the Department of Veterans Affairs through the 250-NETWORK Contract Office 10, with the North American Industry Classification System code 325414 indicating it falls under the manufacturing of in-vitro diagnostic substances. The posting date of April 30, 2026, signals its anticipated activation timeline, though no specific solicitation number or set-aside provisions are provided. Performance of the contract is not tied to a specific geographic location, allowing for potential distribution across VA facilities as needed. The reagents must meet stringent quality and reliability standards to ensure accurate and consistent patient results across VA laboratories.